Cantargia will start the preclinical development of a new antibody, called CAN10, intended to treat people with…
Articles by Alice Melão, MSc
A single dose of an engineered antibody known as CD45-ADC can effectively eliminate disease-causing immune cells and ease the symptoms…
Real-world clinical data support the use of Opsumit (macitentan) to treat people with pulmonary arterial hypertension (PAH)…
Blocking the activity of estrogen may worsen skin fibrosis in people with scleroderma, according to a study in mice.
Raynaud’s Association is launching several activities during October to raise awareness about Raynaud’s phenomenon, and help those affected…
Kadmon Holdings started a Phase 2 clinical trial testing its inhibitor KD025, with the first patient with diffuse cutaneous…
Treatment with pirfenidone fails to improve lung function in patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD),…
Higher blood viscosity may help clinicians identify patients with systemic sclerosis at risk of having pulmonary arterial hypertension (PAH),…
Michigan Medicine researchers have been awarded approximately $10.2 million by the National Institutes of Health (NIH) Autoimmunity Centers of Excellence…
Enrollment has been completed in an ongoing Phase 3 clinical trial assessing the safety and efficacy of experimental therapy…